A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Faculty Opinions recommendation of Evolution of antibody immunity to SARS-CoV-2
[dataset]
2021
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
unpublished
Competing interests The Rockefeller University has filed a provisional patent application in connection with this work on which D.F.R. and M.C.N. are inventors (US patent 63/021,387). R.E.S. is on the scientific advisory board of Miromatrix Inc and is a consultant and speaker for Alnylam Inc. S.M. has served as a consultant for Takeda Pharmaceuticals, Morphic and Glaxo Smith Kline. Z.Z. received seed instruments and sponsored travel from ET Healthcare.
doi:10.3410/f.739380795.793585344
fatcat:ze7ufgrmmbc4vhqlfngvw7b5dy